Conclusion
Compulsory licensing is a blunt sword that may be difficult to use effectively
The threat of compulsory licensing may be effective in establishing differential pricing practices
Compulsory licensing is not an easy answer to solve drug access problems
The primary responsibility for improving access to drugs lies within countries